Back to Article

Antimicrobial Resistance, Bacterial Pathogens, and Risk Factors for Multidrug-Resistant Hospital-Acquired Infections in Erbil City, Iraq

World Journal of Medical Microbiology | Vol 5, Issue 1

Table 3. Antimicrobial Resistance Profile (%) ofBacterial Isolates from Hospital-Acquired Infections

Antibiotic E. coli K. pneumonia S. aureus P. aeruginosa A. baumannii E. cloacae P. mirabilis
Ampicillin 88% 92% 100% 100% 100% 95% 82%
Amox/Clav 75% 80% 85% 90% 95% 78% 70%
Cefazolin 78% 85% 90% 88% 92% 80% 74%
Cefuroxime 70% 78% 88% 85% 90% 72% 65%
Ceftriaxone 65% 75% 85% 80% 88% 68% 60%
Ceftazidime 60% 70% 80% 75% 85% 65% 55%
Cefepime 35% 45% 60% 55% 70% 40% 30%
Pip/Tazo 30% 40% 55% 50% 65% 35% 25%
Imipenem 18% 25% 5% 30% 55% 22% 15%
Meropenem 15% 20% 5% 28% 50% 18% 12%
Amikacin 20% 30% 10% 35% 40% 22% 18%
Gentamicin 45% 55% 40% 50% 65% 48% 42%
Ciprofloxacin 60% 70% 45% 65% 75% 62% 55%
Levofloxacin 55% 65% 40% 60% 70% 58% 50%
TMP/SMX 70% 78% 50% 75% 85% 72% 68%
Colistin 2% 5% 10% 25% 8% 6%

Amox/Clav = Amoxicillin/Clavulanic acid; Pip/Tazo = Piperacillin/Tazobactam; TMP/SMX = Trimethoprim/Sulfamethoxazole; — = Not applicable (intrinsic resistance or not testable). Chi-square, p < 0.001 for inter-species resistance differences.